The TriNation 2021 will be held as a virtual meeting on Microsoft Teams on April 21-22nd from 12.30-16.00 CET.
The meeting will be held in collaboration with the Norwegian Seafood Research fund (FHF). See the program for the meeting below.
To sign up for the meeting, please use the following link: https://www.fhf.no/arrangementer/arrangementer/trination/There is an upper limit of 300 participants, and the registration will close on April 16th. Participants will recieve meeting links two days in advance.
To compensate for the lack of social interaction we will arrange smaller break-out rooms during the breaks.
Below is the confirmed program, updated April 13th.
Day 1: Wednesday April 21st 12.30-16.00 CET
|12.30 -13.40||Welcome and Situation updates|
|12.30||Welcome by Tore Hovland, President TriNation|
|12.40||Scotland by Eann Munro, Marine Scotland|
|13.00||Norway by Hilde Sindre, Norwegian Veterinary Institute|
|13.20||Ireland by Susie Mitchell, Fish Vet Group|
13.40-14.15 Virtual coffee: Breakout rooms
|14.15-15.00||Epidemiology and disease management|
|14.15||How our knowledge of alphavirus infection (PD) in farmed salmon can inform the management of Covid 19 in humans? by Marian McLoughlin, Fish health & production Veterinary consultant|
|14.30||Epidemiology and pathogenesis of Piscine orthoreovirus genotype 3 by Juliane Sørensen, Technical University of Denmark|
|14.45||Sequence variation in the full genome of PMCV sampled from field outbreaks of CMS by Aase B. Mikalsen, NMBU -Faculty of Veterinary Sciences|
|15.15||PRV-3, but not PRV-2, cross-protects against PRV-1 and HSMI in Atlantic salmon by Maria Dahle, Norwegian Veterinary Institute|
|15.30||Experimental challenge trial in Atlantic salmon with PMCV – insights in pathogenesis of CMS by Niccolò Vendramin, Technical University of Denmark|
|15.45||PRV-1 isolates differ in virulence by Øystein Wessel, NMBU – Faculty of Veterinary Sciences|
16.00 End of day 1
Day 2: Thursday April 22nd 12.30-16.00 CET
|12.30-13.40||Development in diagnostics and support|
|12.30||A field evaluation of diagnostic tests for SAV and PD by Mona Dverdal Jansen, Norwegian Veterinary Institute|
|12.45||Field study on the assessment of a method for detection of SAV in seawater at Norwegian Atlantic salmon farms by Lisa-Victoria Bernhardt, Norwegian Veterinary Institute|
|13.00||Identification of serum proteins from Atlantic salmon with CMS by Janina Costa, Moredun Research Institute|
|13.15||Assessing the use of cardiac biomarkers as a health management tool for early diagnostic of CMS in Atlantic salmon by Jorge del-Pozo, University of Edinburgh|
|13.30||Remote customer support project by Claudia Marin, MSD animal health|
13.55-14.10 Information from TriNation
|14.10||Efficacy of licensed PD vaccines administered to commercially reared Atlantic salmon naturally infected with SAV2 and SAV3 in sea cages by Magnus Røsæg, Salmar|
|14.25||Cellular immune responses in rainbow trout following vaccination and challenge against SAV by Kimberly Veenstra, Friedrich Loeffler Institut|
|14.40||Effect of vaccines against CMS by Marius Karlsen, PHARMAQ|
|15.15||Effect and side-effects from PD vaccines by Espen Brudal, PHARMAQ|
|15.30||Effect of DNA and oil-adjuvanted vaccines for PD on spinal pathology, growth and economic impact of commercially reared salmon by Ragnar Thorarinsson, Elanco Animal Health|
|15.45||Duration of immunity in Atlantic salmon parr vaccinated with CLYNAV using a saltwater SAV3 cohabitation challenge model by Ana Silva, Elanco Animal Health|
16.00 End of day 2